Fast, accurate detection and monitoring for health issues that may arise as part of COVID-19 disease management are critical. Our comprehensive portfolio of systems and extensive menu in immunoassay, chemistry, hematology, hemostasis, molecular, and urinalysis, in conjunction with automation, informatics, and services, can help support the essential role of laboratory diagnostics. We are expanding infectious-disease testing capabilities to address the COVID-19 pandemic, developing a SARS-CoV-2 laboratory serology assay3 to detect presence of IgM and IgG antibodies in blood, helping indicate whether a person has developed immunity. An antibody test can reveal if a person had COVID-19 even if they were asymptomatic or never diagnosed with the disease.